Ullrich K J, Rumrich G, Papavassiliou F, Hierholzer K
Max-Planck-Institut für Biophysik, Frankfurt am Main, Federal Republic of Germany.
Pflugers Arch. 1991 May;418(4):371-82. doi: 10.1007/BF00550875.
Using the stop-flow peritubular capillary microperfusion method contraluminal transport of corticosteroids was investigated (a) by determining the inhibitory potency (apparent Ki values) of these compounds against p-aminohippurate (PAH), dicarboxylate (succinate) and sulphate transport and (b) by measuring the transport rate of radiolabelled corticosteroids and its inhibition by probenecid. Progesterone did not inhibit contraluminal PAH influx but its 17 alpha- and 6 beta-hydroxy derivatives inhibited with an app. Ki of 0.36 mmol/l. Introduction of an OH group in position 21 of progesterone, to yield 11-deoxycorticosterone, augments the inhibitory potency considerably (app. Ki, PAH of 0.07 mmol/l). Acetylation of the OH-group in position 21 of 11-deoxycorticosterone, introduction of an additional hydroxy group in position 17 alpha to yield 11-deoxycortisol or in position 11 to yield corticosterone brings the app. Ki, PAH back again into the range of 0.2-0.4 mmol/l. Acetylation of corticosterone or introduction of a third OH group to yield cortisol does not change the inhibitory potency, but, omission of the 21-OH group or addition of an OH group in the 6 beta position reduces or abolishes it. Cortisol and its derivatives prednisolone, dexamethasone and cortisone exert similar inhibitory potencies (app. Ki, PAH 0.12-0.27 mmol/l). But again, omission of the 21-OH group in cortisone or addition of a 6 beta-OH group reduces or even abolishes the inhibitory potency against PAH transport. The interaction of corticosterone was not changed when 11 beta, 18-epoxy ring (aldosterone) was formed. On the other hand, the interaction was considerably augmented if the 11-hydroxy group was changed to an oxo group in 11-dehydrocorticosterone (app. Ki, PAH 0.02 mmol/l). When the A ring of corticosterone is saturated and reduced to 3 alpha, 11 beta-tetrahydrocorticosterone the inhibitory potency is not changed very much. But if more than four OH or oxo groups are on the pregnane skeleton or if the OH in position 21 is missing, the inhibitory potency decreases drastically (app. Ki, PAH 0.7-1.7 mmol/l). Introduction of a 21-ester sulphate into corticosterone, cortisol and cortisone does not change app. Ki, PAH very much. Glucuronidation, however, reduces it (app. Ki, PAH approximately 1.2 mmol/l). None of the tested corticosteroids interacts, in concentrations applicable, with dicarboxylate transport and only the sulphate esters interact with sulphate transport. Radiolabelled cortisol, D-aldosterone, 11-dehydrocorticosterone, and corticosterone are rapidly transported into proximal tubular cells. With the latter three compounds no sign of saturation and no transport inhibition with probenecid could be seen.(ABSTRACT TRUNCATED AT 400 WORDS)
采用停流肾小管周围毛细血管微量灌注法,研究皮质类固醇的对腔转运:(a) 通过测定这些化合物对对氨基马尿酸(PAH)、二羧酸盐(琥珀酸盐)和硫酸盐转运的抑制效力(表观Ki值),以及(b) 通过测量放射性标记皮质类固醇的转运速率及其被丙磺舒的抑制作用。孕酮不抑制对腔PAH内流,但其17α-和6β-羟基衍生物以约0.36 mmol/L的表观Ki值抑制。在孕酮的21位引入一个OH基团,生成11-脱氧皮质酮,显著增强抑制效力(PAH的表观Ki值为0.07 mmol/L)。11-脱氧皮质酮21位的OH基团乙酰化,在17α位引入一个额外的羟基生成11-脱氧皮质醇,或在11位引入生成皮质酮,使PAH的表观Ki值再次回到0.2 - 0.4 mmol/L范围。皮质酮乙酰化或引入第三个OH基团生成皮质醇,不改变抑制效力,但省略21-OH基团或在6β位添加一个OH基团会降低或消除抑制效力。皮质醇及其衍生物泼尼松龙、地塞米松和可的松具有相似的抑制效力(PAH的表观Ki值为0.12 - 0.27 mmol/L)。但同样,可的松中省略21-OH基团或添加一个6β-OH基团会降低甚至消除对PAH转运的抑制效力。当形成11β,18-环氧环(醛固酮)时,皮质酮的相互作用未改变。另一方面,如果在11-脱氢皮质酮中将11-羟基变为氧代基团,相互作用会显著增强(PAH的表观Ki值为0.02 mmol/L)。当皮质酮的A环饱和并还原为3α,11β-四氢皮质酮时,抑制效力变化不大。但如果孕烷骨架上有超过四个OH或氧代基团,或者21位没有OH基团,抑制效力会急剧下降(PAH的表观Ki值为0.7 - 1.7 mmol/L)。在皮质酮、皮质醇和可的松中引入21-酯硫酸盐,对PAH的表观Ki值改变不大。然而,葡萄糖醛酸化会降低它(PAH的表观Ki值约为1.2 mmol/L)。在所测试的皮质类固醇中,没有一种在适用浓度下与二羧酸盐转运相互作用,只有硫酸酯与硫酸盐转运相互作用。放射性标记的皮质醇、D-醛固酮、11-脱氢皮质酮和皮质酮迅速转运到近端肾小管细胞中。对于后三种化合物,未观察到饱和迹象,也未观察到丙磺舒对转运的抑制作用。(摘要截短于400字)